Redeye’s analyst Richard Remanius recently interviewed Oncopeptides CEO Sofia Heigis about Q1 and the application for a broader indication.
The interview is held in Swedish.
Watch the interview via this link (requires free membership at Redeye)
Redeye’s analyst Richard Remanius recently interviewed Oncopeptides CEO Sofia Heigis about Q1 and the application for a broader indication.
The interview is held in Swedish.
Watch the interview via this link (requires free membership at Redeye)
Learn more about the company Oncopeptides and the work we do to redefine cancer care
Learn more about the company Oncopeptides and the work we do to redefine cancer care
Learn more about the company Oncopeptides and the work we do to redefine cancer care
Learn more about the company Oncopeptides and the work we do to redefine cancer care